21st International Congress » Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Date: Monday, June 5, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm: [11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study

P. Vazquez Rodriguez, J. Rowe, J. O'Brien, F. Aigbirhio, T. Fryer, L. Su, E. Mak, A. Surendranathan, R. Borchert, S. Jones, R. Arnold, R. Bevan-Jones, L. Passamonti, Y. Hong (Cambridge, United Kingdom)

1:45pm-3:15pm: A case of Dementia with Lewy Bodies Co-Occuring with Multiple Sclerosis

A. Hannoun, E. DeGrush, K. Smith, T. Kao, A. Deb (Worcester, MA, USA)

1:45pm-3:15pm: A PSP-like phenotype accompanies rapidly progressive dementia

M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)

1:45pm-3:15pm: A registry study of multiple system atrophy in Hokkaido, Japan: HoRC-MSA Project 2014-16

M. Matsushima, K. Sakushima, I. Yabe, Y. Kanatani, Y. Ito, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, M. Mori, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)

1:45pm-3:15pm: Acute L-dopa Challenge Test In Early Parkinsonism With Respect To Presence Of Red Flag Signs &MRIAbnormalitis

M. ACHARYA, A. BISWAS, A. Chatterjee, S. DAS (KOLKATA, India)

1:45pm-3:15pm: Alien Limb Syndrome Induced by a Dopamine Agonist in a Patient with Parkinsonism and Agenesis of the Corpus Callosum

M. Krause, J. Shou, S. Joy, D. Torres-Russotto (Omaha, NE, USA)

1:45pm-3:15pm: An evaluation of the diagnostic utility of radiological biomarkers in PSP

J. Whitwell, G. Hoglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, R. Dodel, T. van Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Respondek, G. Rabinovici, J. Rowe, M. Stamelou, K. Josephs (Rochester, MN, USA)

1:45pm-3:15pm: An unusual mimicker of Lewy Body Dementia: Gliomatosis Cerebri.

H. Oliveira, P. Oliveira, V. Calil, P. Macêdo, N. Canedo, L. Vasconcellos (Rio de Janeiro, Brazil)

1:45pm-3:15pm: Anatomical predictors of survival in PSP: thalamic collapse towards the end of life

W. Bevan-Jones, S. Jones, B. Ghosh, T. Rittman, I. Coyle-Gilchrist, J. Rowe (Cambridge, United Kingdom)

1:45pm-3:15pm: Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

S. Lorenzl (Hausham, Germany)

1:45pm-3:15pm: Association of nocturnal stridor with clinical features of patients with multiple system atrophy

H.-S. Ryu, J.-H. Paek, S. You, M.-J. Kim, Y.J. Kim, J. Kim, K. Kim, S.-A. Lee, S.J. Chung (Seoul, Republic of Korea)

1:45pm-3:15pm: Brain metabolic patterns in progressive supranuclear palsy phenotypes

M.M. Carmona-Abellan, A. Fontes, E. Prieto, J. Arbizu, R. Luquin, M. Riverol (Pamplona, Spain)

1:45pm-3:15pm: Can the level of CSF Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy?

E. Jabbari, J. Woodside, H. Morris (London, United Kingdom)

1:45pm-3:15pm: Cardiac Autonomic Dysregulation in Probable Multiple System Atrophy

M. Rukmani, R. Yadav, P. Pal, B. Bhaskarapillai, T. Sathyaprabha (Bangalore, India)

1:45pm-3:15pm: Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies

C. Spears, A. Besharat, D. Martinez-Ramirez, L. Almeida, M. Armstrong (Gainesville, FL, USA)

1:45pm-3:15pm: Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy

Y. Compta, F. Antonelli, M. Fernandez, P. Bravo, M. Soto, A. Camara, D.M. Giraldo, M.J. Marti, On-behalf-of Catalan-MSA-Registry Group (Barcelona, Spain)

1:45pm-3:15pm: Clinical Phenotype in Patients with Multiple System Atrophy in the Mexican Population

S. Isais-Millán, C. Perez-Lohman, K. Salinas Barboza, A. Cervantes Arriaga, M. Rodriguez Violante, L. Mendoza Vega, N. Davila Avila, A. DelaCruz Landero (Mexico City, Mexico)

1:45pm-3:15pm: Clinicopathological analysis of corticobasal syndrome: a retrospective study

R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

1:45pm-3:15pm: Cognitive Impairment in MSA Patients from the Catalan Multiple System Atrophy Registry (CMSAR)

D. Giraldo, Y. Compta, F. Antonelli, E. Muñoz, A. Camara, J. Pagonabarraga, O. de Fabregués, J. Hernández-Vara, F. Valldeoriola, E. Tolosa, M.C. Pont, S. Jauma, A. Bayes, N. Caballol, M. Calopa, P. Pastor, L. Planellás, M. Pujol, V. Puente, A. Avila, M.J. Martí (Barcelona, Spain)

1:45pm-3:15pm: Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

1:45pm-3:15pm: Corticobasal degeneration and frontotemporal dementia – an overlapping continuum

R. Varela, C. Duque, J. Carvalho, A. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

1:45pm-3:15pm: Creutzfeldt-Jakob Disease with Corticobasal Syndrome-Like Onset: Case report

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

1:45pm-3:15pm: Deep Brain Stimulation in a case with Parkinsonism and SCA2 mutation: case report highlighting challenges and outcome

N. Sarangmat, A. Whone, S. Gill, C. Robbins (Bristol, United Kingdom)

1:45pm-3:15pm: Depression, anxiety and quality of life in Multiple System Atrophy

L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

1:45pm-3:15pm: Development of a Clinician-reported Screening Tool to Identify Patients with Parkinson’s disease inadequately controlled on oral medications

A. Antonini, P. Schmidt, P. Odin, L. Kleinman, A. Skalicky, K. Sail, Y. Jalundhwala, J. Zamudio, K. Onuk, T. Marshall, H. Fernandez (Venice, Italy)

1:45pm-3:15pm: Differential diagnosis and progress monitoring in Progressive Supranuclear Palsy – a potential role of pulmonary function tests

G. Nuebling, C. Abright, M. Schuberth, S. Schoenecker, K. Boetzel, J. Levin, S. Lorenzl (Munich, Germany)

1:45pm-3:15pm: Differential diagnosis of Parkinson’s Disease and Progressive Supranuclear Palsy

Y. Trufanov (Kyiv, Ukraine)

1:45pm-3:15pm: Differential microRNA expression in a cohort of Parkinson’s disease patients

A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

1:45pm-3:15pm: Differentiating Parkinsonism with Spatio-temporal dynamics (real-time MRI) and Acoustics of Speech (spectrogram)

S. GUDWANI, S.S. Kumaran, M. Behari (New Delhi, India)

1:45pm-3:15pm: Diffusion-Weighted MRI discriminates Parkinson´s Disease from the Parkinsonian Variant of Multiple System Atrophy: a Meta-analysis

S. Bajaj, F. Krismer, G. Wenning, W. Poewe, K. Seppi (Innsbruck, Austria)

1:45pm-3:15pm: Do median-nerve evoked blink reflexes allow early differentiation between PD and PSP in patients with debuting parkinsonism?

E. Nordh, J. Linder, L. Forsgren (UMEA, Sweden)

1:45pm-3:15pm: Dynamic Instability and Stride Width in Parkinsonism

P. Fino, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, F. Horak (Portland, OR, USA)

1:45pm-3:15pm: Dysphagia in PSP

H. Clark, J. Whitwell, J. Ahlskog, K. Josephs (Rochester, MN, USA)

1:45pm-3:15pm: Effect of low frequency stimulation on freezing of gait in a PSP patient with bilateral STN DBS

T. Xie, M. Padmanaban (Chicago, IL, USA)

1:45pm-3:15pm: Epidemiological profile of parkinsonism in a tertiary neurological clinic in the northeast of Brazil.

R. Prado, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

1:45pm-3:15pm: Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy

P. Dowell, B. Patel, L. Ledbetter, K. Lyons, R. Pahwa (Kansas City, KS, USA)

1:45pm-3:15pm: Evaluation of mitochondrial dysfunction in fibroblasts and iPSC-derived dopaminergic neurons of patients affected by Multiple System Atrophy

G. Monzio Compagnoni, E. Frattini, F. Fortunato, D. Ronchi, A. Bordoni, M. Garbellini, S. Salani, M. Guida, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milano, Italy)

1:45pm-3:15pm: Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study

M. Rizzone, F. Dematteis, A. Chiò, S. Cammarosano, C. Artusi, M. Pagani, F. Nobili, A. Cistaro, M. Balma, E. Montanaro, B. Iazzolino, A. Canosa, L. Lopiano, A. Calvo (Torino, Italy)

1:45pm-3:15pm: Freezing of gait is an early clinical feature of progressive supranuclear palsy

Y. Osaki, Y. Morita, Y. Miyamoto, T. Furushima, K. Furuta, H. Furuya (Nankoku, Japan)

1:45pm-3:15pm: Gait and Cognition in Progressive Supranuclear Palsy: A Significant Association

K. Chatterjee, B. Mondal, S. Choudhury, H. Kumar (Kolkata, India)

1:45pm-3:15pm: Gait characteristics in Atypical Parkinsonism

S. Radovanovic, M. Jecmenica-Lukic, I. Petrovic, N. Dragasevic-Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

1:45pm-3:15pm: Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.

S. O'Shea, O. Levy, J.P. Vonsattel, E. Cortes, K. Marder, H. Mitsumoto, R. Alcalay (New York, NY, USA)

1:45pm-3:15pm: Gut Microbiota in Multiple System Atrophy

A.H. Tan, C.W. Chong, S.-L. Song, C.S.-J. Teh, I.K.-S. Yap, M.F. Loke, Y.Q. Tan, H.S. Yong, S. Mahadeva, A.E. Lang, S.-Y. Lim (Kuala Lumpur, Malaysia)

1:45pm-3:15pm: Impulse control disorders in Parkinson’s disease; description of a New Zealand cohort

A. Garvey, S. Buchanan, N. Cutfield (Dunedin, New Zealand)

1:45pm-3:15pm: Intrathecal Administration of Autologous Mesenchymal Stem Cells in Multiple System Atrophy – A Phase I/II Dose-Escalation Trial

W. Singer, A. Dietz, A. Zeller, T. Gehrking, J. Schmelzer, D. Sletten, J. Gehrking, E. Coon, P. Sandroni, E. Benarroch, R. Fealey, J. Matsumoto, J. Bower, J. Ahlskog, A. Hassan, A. McKeon, B. Klassen, P. Low (Rochester, MN, USA)

1:45pm-3:15pm: Levodopa induced dyskinesia in a case of progressive supranuclear palsy.

T. Yamamoto, H. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, K. Takahashi, N. Tamura, N. Araki (Saitama, Japan)

1:45pm-3:15pm: Lifetime exposure to estrogen and risk for progressive supranuclear palsy

H.K. Park, I. Litvan, S. Ilango (Goyang-si, Republic of Korea)

1:45pm-3:15pm: Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort

D. Aleksovski, D. Miljkovic, A. Antonini (Ljubljana, Slovenia)

1:45pm-3:15pm: Metabolomics study in a group of Parkinson’s disease patients from Northern India

G.N. Babu, M. Gupta, V.K. Paliwal, S. Singh, R. Roy (Lucknow, India)

1:45pm-3:15pm: Movement Disorder Society – Clinical Diagnostic Criteria for Progressive Supranuclear Palsy

G. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. Josephs, A. Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. Whitwell, A. Boxer, L. Golbe, I. Litvan (Munich, Germany)

1:45pm-3:15pm: Movement disorders caused by benign brain tumor

A.M. Magnerou, P.E. Sounga Bandzouzi, H.F. Ngoungoure, M.M. Ndiaye (DAKAR, Senegal)

1:45pm-3:15pm: Mutational analysis of COQ2 in Chinese patients with multiple-system atrophy

J. Zhang, Y. Hao, Y. Chen, M. Ding, X. Zhang, W. Gu (Beijing, China)

1:45pm-3:15pm: Neuroactive steroids reverse the dopaminergic neurotransmission defectiveness in chronic hepatic (HE) encephalopathy: a possible involvement in HE related parkinsonism

O. El Hiba, A. EL Khiat, H. Gamrani (EL Jadida, Morocco)

1:45pm-3:15pm: Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy

K.J. Kim, J.-M. Kim (Seongnam-Si, Republic of Korea)

1:45pm-3:15pm: Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy

C. Pellicano, F. Assogna, N. Cellupica, M. Pierantozzi, A. Stefani, R. Cerroni, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

1:45pm-3:15pm: Non-motor symptoms and gender differences in multiple system atrophy

S. Eschlboeck, T. Benke, S. Bösch, M. Delazer, A. Djamshidian-Tehrani, A. Fanciulli, R. Granata, B. Högl, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, G. Wenning (Innsbruck, Austria)

1:45pm-3:15pm: Parkinsonism in Human African Trypanosomiasis: Clinical course, imaging findings and treatment-related challenges.

A. Aggarwal, T. Singhal, P. Borade, L. Hachaambwa, M. Munshi, D. Sanghvi, P. Dutta, A. Shrivastava (Mumbai, India)

1:45pm-3:15pm: Parkinsonism in Patients with Alzheimer Disease and Epileptic Seizures

I. Petrov (Skopje, The former Yugoslav Republic of Macedonia)

1:45pm-3:15pm: Parkinsonism Revealing Cerebral Hematoma with Moya Moya Disease

z. brahem, i. bedoui, a. riahi, m. mansour, j. zaouali, r. mrissa (tunis, Tunisia)

1:45pm-3:15pm: Parkinsonism through astrocytic GABA induce motor symptoms

M.J. Lee, Y. Jang, J. Han, S.J. Kim, J. Kim, I. Ryu, X. Ju, M.J. Ryu, S.-Y. Choi, G.R. Kweon (Daejeon, Republic of Korea)

1:45pm-3:15pm: Perceptual and acoustical analysis of speech in multiple system atrophy and progressive supranuclear palsy.

S. Contardi, A. Gessani, F. Cavallieri, C. Budriesi, A. Bernardi, M. Tondelli, E. Menozzi, A. Chiari, P. Nichelli, F. Valzania (Modena, Italy)

1:45pm-3:15pm: PET-MRI Imaging in Parkinson Dementia Complex of Guam: A Case Report

A. Tran, K. Chan, V. Kharidi, E. Goldstein, R. Burns, P. Reyes (Phoenix, AZ, USA)

1:45pm-3:15pm: Phenotypic Heterogeneity in PSP Variants – A Case Series

S. BHADRAN, S. ABRAHAM, B. NATARAJAN, A. MEKKATTUKUNNEL, J. KRISHNAN, R. ISAAC, P.K. PAL (THRISSUR, India)

1:45pm-3:15pm: Pre-synaptic dopaminergic deficit in a patient with familial FTD

M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

1:45pm-3:15pm: Predictors of cognitive impairment in multiple system atrophy

M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

1:45pm-3:15pm: Primary progressive apraxia: an unusual ideomotor syndrome

Y. Fernandez, S. Frucht (New York, NY, USA)

1:45pm-3:15pm: Profound reduction of DAT-SPECT signal in multiple system atrophy (MSA)

I. Toyoshima, T. Hatakeyama, E. Abe, C. Wada, M. Kobayashi, K. Obara (Yurihonjo, Japan)

1:45pm-3:15pm: Progression of milestones by clinical types in progressive supranuclear palsy: a longitudinal observational study of a cohort of patients with PSP/CBD (the JALPAC project)

I. Aiba, T. Ikeuchi, H. Takigawa, T. Shimohata, T. Tokuda, M. Morita, O. Onodera, S. Murayama, K. Hasegawa, K. Nakashima (Nagoya, Japan)

1:45pm-3:15pm: Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)

1:45pm-3:15pm: Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

1:45pm-3:15pm: Randomize study of occurrence of Parkinson’s syndrome in patients with rheumatoid arthritis.

M. Mavlanov, S. Aslanova, G. Rakhimbaeva (Tashkent, Uzbekistan)

1:45pm-3:15pm: Rare presentation of acute secondary parkinsonism in the post partum period.

D. Desai, S. Desai (Anand, India)

1:45pm-3:15pm: REM sleep behavior disorder: Is it useful to differentiate between Parkinson disease and Progressive Supranuclear Palsy?

H. Gupta, S. Mehta, J. Hentz, H. Shill, E. Driver-Dunckley, M. Sabbagh, C. Belden, B. Dugger, T. Beach, G. Serrano, L. Sue, C. Adler (Scottsdale, AZ, USA)

1:45pm-3:15pm: Results of a Phase 1, Single Ascending Dose, Placebo-Controlled Study of ABBV-8E12 in Patients with Progressive Supranuclear Palsy and Phase 2 Study Design

N. Mendonca, T. West, J. Braunstein, I. Fogelman, Y. Bordelon, I. Litvan, E. Roberson, H. Hu, P. Verghese, R. Bateman, H. Florian, D. Wang, D. Ryman, L. Gault, K. Budur, B. Rendenbach-Mueller, D. Kerwin, A. Boxer, D. Holtzman (Ludwigshafen, Germany)

1:45pm-3:15pm: Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice

N. KUMAR, R. Khanna (Jaipur, India)

1:45pm-3:15pm: Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

D. Akramova (Tashkent, Uzbekistan)

1:45pm-3:15pm: Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

1:45pm-3:15pm: Serum Mir-30c as a Potential Biomarker to Discriminate MSA from PD Patients: A Pilot Study.

A. Vallelunga, M. Sessa, D. Giovanna, M. Picillo, P. Barone, M.T. Pellecchia (Salerno, Italy)

1:45pm-3:15pm: Sudden onset of parkinsonism in a case of dural arteriovenous fistula

H. Kawasaki, T. Yamamoto, A. Miyake, K. Ikeda, T. Mistuhuji, Y. Ito, K. Takahashi, N. Tamura, N. Araki (Moroyama, Japan)

1:45pm-3:15pm: Tau Network Genes in a Genome Wide Association Study of Progressive Supranuclear Palsy

T. Chang (Los Angeles, CA, USA)

1:45pm-3:15pm: The clinical phenotype of progressive supranuclear gaze palsy with predominant cerebellar ataxia (PSP-C): a case series

Z. Xu, T. Lim, W.L. Au, L. Tan (Singapore, Singapore)

1:45pm-3:15pm: The diagnostic challenges of patients with possible multiple system atrophy

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

1:45pm-3:15pm: The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population

M.-C. Kuo, Y.-C. Lu, M.-L. Chen, C.-H. Tai, C.-H. Lin, R.-M. Wu (Taipei, Taiwan)

1:45pm-3:15pm: The phenotypic spectrum of patients with progressive supranuclear palsy

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

1:45pm-3:15pm: The predictor factors for survival in Chinese Multiple System Atrophy patients

B. Cao, L. Zhang, Y. Zou, Q. Wei, R. Ou, Y. Chen, J. Yang, Y. Wu, H. Shang (Chengdu, China)

1:45pm-3:15pm: The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease

T. Yamamoto, M. Asahina, Y. Yamanaka, T. Uchiyama, S. Hirano, M. Fuse, Y. Koga, R. Sakakibara, S. Kuwabara (Chiba, Japan)

1:45pm-3:15pm: To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population

M. Modi, R. Shree, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)

1:45pm-3:15pm: Tongue Strength in PSP

H. Clark, J. Whitwell, J. Ahlskog, K. Josephs (Rochester, MN, USA)

1:45pm-3:15pm: Tyrosine kinase inhibition clears Tau and reserves neuropathology and motor symptoms in a novel model of progressive supranuclear palsy

Y. Torres-Yaghi, F. Pagan, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, M. Javidnia, M. Hebron, C. Moussa (Washington, DC, USA)

1:45pm-3:15pm: Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy

M. Jecmenica Lukic, T. Pekmezovic, I. Petrovic, A. Tomic, M. Svetel, V. Kostic (Belgrade, Serbia)

1:45pm-3:15pm: Utility of THK-5351 tau-PET for differential diagnosis in patients with hypokinetic-rigid syndromes.

G. Rohrer, S. Schönecker, M. Brendel, J. Havla, G. Höglinger, S. Lindner, C. Zach, F. Vettermann, C. Prix, G. Nübling, P. Bartenstein, K. Furukawa, A. Ishiki, N. Okamura, K. Bötzel, A. Rominger, J. Levin (Munich, Germany)

1:45pm-3:15pm: Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy

W. Meissner, F. Bassil, P. Guerin, N. Dutheil, Q. Li, M. Klugmann, E. Bezard, P.-O. Fernagut (Bordeaux, France)

1:45pm-3:15pm: Which clinical features predict progressive supranuclear palsy pathology? A clinicopathological study on 437 autopsy cases and a literature review

G. Respondek, C. Kurz, T. Arzberger, E. Gelpi, D. Irwin, W. Meissner, A. Pantelyat, A. Rajput, J. Van Swieten, C. Troakes, K. Josephs, A. Lang, U. Mueller, C. Nilsson, Y. Bordelon, J.-C. Corvol, A. Boxer, L. Golbe, I. Litvan, M. Stamelou, G. Hoeglinger (Munich, Germany, Germany)

1:45pm-3:15pm: α-Synuclein Preformed Fibrils Induce Disruption of Myelin Basic Protein Expression in Primary Oligodendrocyte Culture; Deciphering Glial Pathology in Multiple System Atrophy

S. Kaji, T. Maki, N. Uemura, R. Takahashi (Kyoto, Japan)

« View all sessions from the 21st International Congress.